Rural-Urban Differences Seen in Hospitals' Pediatric Services
By Lori Solomon HealthDay Reporter
WEDNESDAY, Oct. 2, 2024 -- Children with medical complexity (CMC) who reside in rural areas are significantly more likely to present to hospitals without dedicated pediatric services, according to a study published online Sept. 24 in JAMA Network Open.
JoAnna K. Leyenaar, M.D., Ph.D., from Children’s Hospital at Dartmouth-Hitchcock Medical Center in Lebanon, New Hampshire, and colleagues assessed availability of pediatric services for CMC presenting at acute care hospitals. The analysis included all-payer claims data from children living in Colorado, Massachusetts, and New Hampshire from 2012 to 2017.
The researchers identified 36,943 CMC who experienced 79,906 hospitalizations. They found that rural-residing CMC were 6.55 times more likely to present to hospitals without dedicated pediatric services and 2.03 times more likely to present to hospitals without pediatric beds compared to urban-residing CMC. There were no significant differences in interfacility transfer rates. Rural-residing CMC had an increased risk for in-hospital mortality (rate ratio, 1.44), but when adjusting for clinical characteristics, the difference in in-hospital mortality was no longer significant. Rural-urban outcomes were not modified significantly by index hospital type, but interfacility transfer was a significant modifier of rural-urban differences in surgical safety events.
"These findings suggest that efforts are justified to ensure that all hospital types are prepared to care for CMC," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-10-03 06:00
Read more
- Half of U.S. Teens Stare at Screens More Than 4 Hours Per Day
- ACAAI: ICS + Formoterol and ICS + SABA Better Than SABA Alone for Asthma
- Syndax Announces Positive Pivotal Topline Results from Relapsed or Refractory mNPM1 AML Cohort in AUGMENT-101 Trial of Revumenib
- Doctors Report First U.S. Cases of Sexually Transmitted Ringworm Rash
- Poll Finds Many Parents Struggling to Manage Kids' Anger
- Diagnostic Device Spots Malaria Without Need for Blood Sample
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions